Events

Search Language

English | Use language selector above (below, on mobile) to search additional languages
  • Selected filters
  • x(Orrick%252525252525252525252525252525252525252525252525252525252525252525252BLibrary)

715 items matching filters

Search Results

Events

Founder Legal Boot Camp #3

The third edition of Orrick’s Founder Legal Boot Camp – together with RWTH Innovation, WHU Entrepreneurship Center and TUM Venture Labs.

Events

Post-Issuance Compliance Workshop

JOIN BLX AND ORRICK AT THE POST-ISSUANCE COMPLIANCE WORKSHOP A Comprehensive Overview of Post-Issuance Tax Law and SEC Secondary Market Disclosure for 501(c)(3) Organizations and State and Local Government Issuers Who Utilize Tax-Exempt Financing Virgin Hotels Nashville and Virtual - November 3-4, ...

Events

A Word About Wind’s 2022 Financing Wind North America Conference

Orrick is proud to sponsor A Word About Wind’s 2022 Financing Wind North America Conference, where Blake Winburne will moderate the “Offshore Wind: Is the Momentum now Unstoppable?” panel discussion on opportunities and challenges for the U.S. offshore wind sector and building a robust supply ...

Events

Privacy + Security Forum Fall Academy

Members of Orrick’s Cyber, Privacy & Data Innovation Group are leading panels on privacy for children and teens in the United States (U.S.) and online safety in the United Kingdom (UK) during the Privacy + Security Forum Fall Academy hosted by the Privacy + Security Academy. The Privacy + Security ...

Events

U.S. State Law Compliance Training - It's Not Too Late to Get Started!

Are you prepared for the new United States (U.S.) privacy laws? Download the program materials or watch the training recording led by Orrick’s Cyber, Privacy & Data Innovation Group on the new state privacy laws in California, Virginia, Connecticut, Colorado and Utah.

Events

Are there still opportunities in China and Asia for US biopharmas?

China is the second largest pharmaceutical market in the world, growing to $205bn by 2026. With an increasing focus on innovation and early access, many US biopharmas have found that an anchor in China supports accelerated clinical development and creates incremental value via either through equity ...